Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2026-02-24 @ 12:13 AM
Study NCT ID:
NCT01012492
Status:
COMPLETED
Last Update Posted:
2019-11-21
First Post:
2009-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
Sponsor:
Boston Children's Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | AML | View |
| None | ALL | View |
| None | Undifferentiated Leukemia | View |
| None | Biphenotypic Leukemia | View |
| None | Refractory Anemia | View |
| None | Refractory Anemia With Ringed Sideroblasts | View |
| None | Refractory Cytopenia With Multilineage Dysplasia | View |
| None | Ref. Cytopenia w Multilineage Dysplasia & Ringed Sideroblasts | View |
| None | Refractory Anemia With Excess Blasts-1 (5-10% Blasts) | View |
| None | Refractory Anemia With Excess Blasts-2 (10-20% Blasts) | View |
| None | Myelodysplastic Syndrome, Unclassified | View |
| None | MDS Associated With Isolated Del (5q) | View |